Steven Mylonas
Bottomcatcher.com
Selecta Biosciences, Inc., is a clinical-stage biopharmaceutical company, which researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases.
Market Cap: US$347.1M
One Year Return 107.7%
Over the past 2 weeks, we've seen significant insider buying at SELB (2) which can be construed as a positive sign for higher share prices. Since the 2018 decline, SELB's share price has ranged much throughout 2019 to present and is now testing the multi-year inside trendline at (1). It has to be said that this week the share price has held up quite well considering the sharp sell-off on the U.S. Indexes. Confirmation that SELB is finally about to break out of its long term bottoming pattern, will become apparent if we can convincingly break, hold and close above the inside trendline on the weekly time frame, preferably above the 4.70 handle, which in turn should invite more investors to the table.
Bottomcatcher has made every attempt to ensure the accuracy and reliability of the information provided in this report. However, the information is provided without a warranty of any kind. Views expressed in this report may be subject to change without prior notice and may differ or be contrary to opinions expressed by Bottomcatcher.
Recommended Content
Editors’ Picks
EUR/USD holds gains near 1.0650 amid risk reset
EUR/USD is holding onto its recovery mode near 1.0650 in European trading on Friday. A recovery in risk sentiment is helping the pair, as the safe-haven US Dollar pares gains. Earlier today, reports of an Israeli strike inside Iran spooked markets.
GBP/USD recovers toward 1.2450 after UK Retail Sales data
GBP/USD is rebounding toward 1.2450 in early Europe on Friday, having tested 1.2400 after the UK Retail Sales volumes stagnated again in March, The pair recovers in tandem with risk sentiment, as traders take account of the likely Israel's missile strikes on Iran.
Gold price defends gains below $2,400 as geopolitical risks linger
Gold price is trading below $2,400 in European trading on Friday, holding its retreat from a fresh five-day high of $2,418. Despite the pullback, Gold price remains on track to book the fifth weekly gain in a row, supported by lingering Middle East geopolitical risks.
Bitcoin Weekly Forecast: BTC post-halving rally could be partially priced in Premium
Bitcoin price shows no signs of directional bias while it holds above $60,000. The fourth BTC halving is partially priced in, according to Deutsche Bank’s research.
Geopolitics once again take centre stage, as UK Retail Sales wither
Nearly a week to the day when Iran sent drones and missiles into Israel, Israel has retaliated and sent a missile into Iran. The initial reports caused a large uptick in the oil price.